This study is aimed at studying if PPARG sensitizes hypopharyngeal squamous cell carcinoma (HSCC) in chemotherapeutic treatments and at dissecting possible mechanisms of observed effects. This evidence concerns the gene PPARG and hypopharynx squamous cell carcinoma.